In a lab where blood samples are frozen, a single tube can tell you more about the brain than some scans. Blood doesn't just flow through vessels; it carries traces of cell proliferation, and those traces, it turns out, echo the contours of vulnerable brain regions.
Researchers from the LBC1936 cohort followed 1091 people three times: at ages 73, 76, and 79. They didn't sequence DNA but looked at chemical tags, methylation, which changes with clonal expansion. Two independent algorithms, COMET and CIMS, assessed clone burden from these tags. It turned out that people with a higher clonal burden at 73 had on average smaller brains, and over the next six years their gray matter declined faster. What's more, the pattern of this decline resembles the atrophy map of Alzheimer's disease: a correlation of r = 0.357, comparable to the effect of family history. Yet the hippocampus, a key memory structure, remains untouched, and the caudate nucleus even holds up better in clone carriers.
The link between blood and brain doesn't mean clones directly destroy neurons. Rather, it's a parallel pathway of vulnerability: a shared aging process that manifests in both blood and brain. After adjusting for blood cell composition, the regional associations weaken, and the spatial correlation with the Alzheimer's map loses significance (r = 0.230, p = 0.059). That's an important signal: methylation may reflect not only clonality but also age-related systemic inflammation.
For now, this is a research tool, not a clinical test. But if blood methylation proves to be a reliable proxy for clonal hematopoiesis, it could be used in cohorts without sequencing to screen for systemic neurodegeneration risk. A shadow in the blood, tracing the contours of the brain, might serve as an early warning long before symptoms appear.
The 2% variant allele frequency threshold for a CHIP diagnosis was not chosen at random: below that fraction, it is technically hard to tell true expansion from sequencing noise. But error-corrected studies show that among people over 80, clones with a frequency of 1% or more turn up in 62%, meaning most older adults carry traces of clonal expansion in their blood, even if they do not formally meet the criteria for CHIP.
The idea that mutations in blood cells can affect the brain echoes Greg Egan's novel Quarantine: there, neuron modifications and systemic changes to the body lead to unpredictable cognitive consequences. In a gentler form, the theme of blood as a carrier of aging is played out in the film In Time (2011), where life resources literally flow between people.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.